Aimmune says shutdown blocks peanut allergy drug review

Aimmune says shutdown blocks peanut allergy drug review

Submitted by admin on January 15, 2019 - 9:53am
Source: 
Fierce Biotech
News Tags: 
Aimmune Therapeutics
peanut allergy
AR101
FDA
government shutdown
Headline: 
Aimmune says shutdown blocks peanut allergy drug review
snippet: 

Aimmune Therapeutics has confirmed that the government shutdown will delay the FDA’s review of AR101, its oral immunotherapy for peanut allergy.


Do Not Allow Advertisers to Use My Personal information